Skip to main content

ENFOQUE TERAPEUTICO PARA LOS TRASTORNOS DE LA RETINA ASOCIADOS A PRPH2: EDICION DE CALIDAD Y AMPLIFICACION GENICA PARA TERAPIA GENICA DIRIGIDA

PID2024-156526OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para la Investigación y el Desarrollo Experimental
Subprogram Subprograma Estatal de Generación de Conocimiento Científico-Técnico y Desarrollo Experimental
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2024
State Plan 2024-2027 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD DE ALICANTE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Circadian disruption exacerbates oxidative stress and degeneration in the rd10 mouse model of retinitis pigmentosa

  • Lax, Pedro
  • Ruiz-Conca, Mateo
  • Martínez Gil, Natalia
  • Vidal Gil, Lorena
  • Sánchez-Castillo, Carla
  • Cuenca, Nicolás
  • Lax, Pedro|||/items/4cc55375-3e6f-40f5-b3dc-8b55eb7dd8a7
  • Ruiz-Conca, Mateo|||/items/974b72ef-4765-4691-ba3c-5dae706781b4
  • Martínez Gil, Natalia|||/items/ad7c5d2c-84d3-42a8-9b4a-65b734e47450
  • Vidal Gil, Lorena|||/items/2cd5d051-5b7f-4172-97b5-31dd64887011
  • Sánchez-Castillo, Carla|||/items/03d56d2b-f46a-497a-a442-751626b245e1
  • Cuenca, Nicolás|||/items/9aff7e32-82c7-4c3b-9e61-c644ea7f9ec8
Eye disorders and vision loss have been associated with circadian misalignment and disruption. Nevertheless, growing evidence supports a bidirectional interaction between circadian dysfunction and neurodegeneration, leading to the proposal of circadian disruption as a significant contributing factor to neurodegenerative disorders. This study aimed to assess the impact of disrupting lighting conditions on the circadian rhythmicity and the retinal degenerative process in retinitis pigmentosa mice. Homozygous rd10 mice were maintained under a conventional 12:12 h LD cycle or under an ultradian 3:3 h LD cycle from P19 to P27. Spontaneous locomotor activity was continuously recorded during this period. At P27, retinal responsiveness was assessed by electroretinography, retinal thickness was measured by OCT, and the oxidative stress of the retina was evaluated. Locomotor activity recordings showed deterioration in the circadian rhythmicity of LD 3:3 mice, with small circadian amplitude, low phase homogeneity and loss of circadian periodicity. Besides, retinal responsiveness decreased in LD 3:3 mice, with significant differences between the two groups for b-wave amplitudes. Mean retinal thickness also decreased in LD 3:3 mice. Finally, LD 3:3 mice showed increased levels of DHE fluorescence at the photoreceptor plane, indicating increased oxidative stress. This study provides evidence that exposure to LD 3:3 cycles induces circadian disruption, enhances oxidative stress in photoreceptors and exacerbates retinal degeneration in retinitis pigmentosa mice.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

Shared household environment structures the gut microbiota in a large family cohort with central areolar choroidal dystrophy

  • García-Gutiérrez, Enriqueta
  • Ponsero, Alise J.
  • Delgado, Jesús
  • Crispie, Fiona
  • Cotter, Paul D.
  • Cuenca, Nicolás|||/items/9aff7e32-82c7-4c3b-9e61-c644ea7f9ec8
  • Lax, Pedro|||/items/4cc55375-3e6f-40f5-b3dc-8b55eb7dd8a7
Central areolar choroidal dystrophy (CACD) is a rare monogenic hereditary retinal dystrophy characterised by progressive retinal pigment epithelium and choriocapillaris atrophy, photoreceptor loss, oxidative stress, and chronic inflammation. Emerging evidence suggests that the gut microbiota can modulate systemic inflammatory responses and may influence ocular health through the gut-eye axis. However, the contribution of the gut microbiota to CACD remains unexplored. In this pilot study, we investigated the gut microbiota composition of members of a large Spanish family carrying the PRPH2 Arg195Leu mutation associated with CACD. Faecal samples from 33 mutation carriers and 24 non-carrier household members were analysed using whole-metagenome shotgun sequencing. Taxonomic composition and bacterial diversity were compared adjusting for sequencing depth, age, and sex, accounting for shared household environment through paired and mixed-effects analyses. The findings suggest that gut microbiota variation in this CACD cohort is primarily driven by shared environmental factors rather than disease status at this depth of sequencing. Our study highlights the critical importance of accounting for household effects in microbiome studies of familial and rare genetic diseases and provides a robust framework for future investigations into the gut-eye axis using longitudinal or interventional designs.
RUA. Repositorio Institucional de la Universidad de Alicante
Publication Otros (Other)

MFSD2A, the major transporter of omega-3 DHA in the central nervous system, is expressed in the neural cells of the retina

  • Ruiz-Pastor, María José
  • Sánchez-Sáez, Xavier
  • Lax, Pedro
  • Cuenca, Nicolás
  • Sánchez-Sáez, Xavier|||/items/add0c6bc-499e-4616-aaf4-303fdcb95cb7
  • Lax, Pedro|||/items/4cc55375-3e6f-40f5-b3dc-8b55eb7dd8a7
  • Cuenca, Nicolás|||/items/9aff7e32-82c7-4c3b-9e61-c644ea7f9ec8
Docosahexaenoic acid (DHA) is an essential omega-3 fatty acid indispensable for neural tissue, with anti-inflammatory and neuroprotective properties. Numerous dietary supplements enriched in omega-3 fatty acids were tested in patients with neurodegenerative diseases, as decreased levels of DHA were demonstrated in the central nervous system and plasma of patients and animal models. However, these therapies did not fully report a positive effect. The transport mechanism of DHA to neural tissue remains poorly understood. It was described that the endothelium of the blood–brain and blood-retina barriers expresses the protein major facilitator superfamily domain 2A (MFSD2A), described as the major transporter for DHA. Nevertheless, how neurons incorporate the fatty acid is unknown. Herein, we hypothesized that neurons could express MFSD2A to internalize DHA. We studied the expression of MFSD2A in neural and non-neural retinal cells of humans and other animals. We are the first to demonstrate that the major transporter for the omega-3 fatty acid is expressed not only in retinal blood vessels but also in retinal cells of all animals studied. We performed immunofluorescence in retinal sections of human and other representative non-human animals from different taxonomic orders using three commercial anti-MFSD2A antibodies. To test the specificity of antibodies, pre-absorption control and Western blot were performed. We also did double immunostaining with specific cell markers to identify the different populations of retinal cells. The anti-MFSD2A antibodies tested reported a similar pattern of immunostaining. We confirmed the expression of MFSD2A in the retinal vessels, but we also described the expression of the transporter in both neural and non-neural cells in the retina. Expression of MFSD2A was demonstrated in both rod and cone photoreceptor cells, bipolar cells, horizontal cells, amacrine cells, and ganglion cells of all vertebrates studied. Concerning the non-neural retinal cells, we emphasized the expression of the transporter in Müller cells, because of their known role in retinal homeostasis. Retinal pigment epithelium​, which is involved in nutrient supply to photoreceptors, was immunopositive for MFSD2A in frogs, cats, and dogs. Human Iba-1+ microglial cells did not express the transporter. This is the first study that describes the expression of MFSD2A in the neural retina. Both neural and non-neural retinal populations expressed MFSD2A, being conserved in all the animal species studied, regardless of their phylogenetic distance to Homo sapiens.